YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $3,532 | $3,518 | $3,449 | $3,509 |
| - Cash | $1,404 | $1,523 | $1,674 | $3,782 |
| + Debt | $2,235 | $2,339 | $2,609 | $4,480 |
| Enterprise Value | $4,364 | $4,334 | $4,384 | $4,207 |
| Revenue | $1,269 | $2,455 | $3,086 | $3,209 |
| % Growth | -48.3% | -20.4% | -3.8% | – |
| Gross Profit | $845 | $1,949 | $2,422 | $2,564 |
| % Margin | 66.6% | 79.4% | 78.5% | 79.9% |
| EBITDA | -$7,936 | $9,007 | $1,499 | $1,660 |
| % Margin | -625.4% | 366.9% | 48.6% | 51.7% |
| Net Income | -$202 | $685 | $963 | $1,029 |
| % Margin | -15.9% | 27.9% | 31.2% | 32.1% |
| EPS Diluted | -0.23 | 0.78 | 1.09 | 1.17 |
| % Growth | -129.5% | -28.4% | -6.8% | – |
| Operating Cash Flow | $65 | $24 | $428 | $1,245 |
| Capital Expenditures | -$780 | -$402 | -$128 | -$216 |
| Free Cash Flow | -$715 | -$377 | $300 | $1,029 |